Diabetes, weight management, next generation of GLP-1RA's

Endocrinologist Dr Rinki Murphy will review the role of GLP-1 receptor agonists and introduce tirzepatide, a dual GIP/GLP-1 receptor agonist, outlining how its mechanism of action and clinical effects differ from existing GLP-1 therapies.

Register here.

For more information email the Goodfellow Unit.